Please login to the form below

How to get management buy-in for content marketing

Pharma content marketing is still fairly new in the scheme of things for the pharma industry. In the conservative and traditional pharma industry that’s fraught with regulations, getting management buy-in to adopt it can be challenging.

However for the need of providing a service, providing content can act as an effective outreach programme. So you’re going to need all the ammunition at your disposal if you want to get a percentage of your budget allocated for the development of content. Here are the 4 primary reasons why pharma needs to embrace the new content marketing landscape without delay:

It’s taking over from traditional marketingFor the faint of heart, here’s a caveat: it doesn’t have to be all or nothing! Your top management team doesn’t have to envisage giving up traditional marketing overnight. You can use a phased-in approach to shift the focus from pushing information at customers to finding ways to let them know what you have available so they come looking for it.There’s little point in flogging a dead (and expensive!) horse, however, and sooner or later management will realise it. The trick is to give them something they’re comfortable with to focus on when they do, so they have somewhere to shift to. 

Provides information “Just in Time”You’ve heard of just-in-time production, correct? Well, content is just-in-time marketing. By creating information for every stage in the customer’s buying cycle, you can ensure that whatever your prospect comes looking for is available for him to find. No more guessing or having to quiz the prospect about where he’s at or what he’s looking for; it’s all there for him to choose from. This is the difference between sales and service; which do you think your client is going to choose?

To continue reading this post visit:

2nd May 2016



Company Details


+44 (0) 161 818 8399

Contact Website

4th Floor, Churchgate House
56, Oxford Street
M1 6EU
United Kingdom

Latest content on this profile

How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns.
How to design digital health behaviour change initiatives
Effecting digital health behaviour change is a challenging arena for pharma. Here's how and why a multidisciplinary research approach increases engagement
Why pharma content marketing campaigns should be agile
Agile pharma content marketing is simply about responding to customer needs, rather than your own whims.
The three steps of persona mapping
This blog gives a breakdown of the key stages of persona mapping for pharma marketing campaigns.
Crowdsourcing innovation: Learnings from Pfizer’s Get Old campaign
If pharma is to truly engage with patients and the wider world, it must embrace the innovation of crowdsourcing – and reap the benefits of doing so.
Where is health behaviour change heading?
Cures rely on patient adherence to succeed, and health behaviour change in any non-compliant patient is essential, this post explores where health behaviour change is heading.